Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation
MA Sammut, D Conway, J Iqbal… - Expert Review of …, 2024 - Taylor & Francis
Background Triple antithrombotic therapy (TAT) with aspirin, a P2Y12 inhibitor, and oral
anticoagulation in patients with atrial fibrillation (AF) undergoing percutaneous coronary …
anticoagulation in patients with atrial fibrillation (AF) undergoing percutaneous coronary …
Spoiled for Choice: P2Y12 Receptor Inhibition in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
The selection of optimal antithrombotic therapy in patients with nonvalvular atrial
fibrillation(AF) undergoing percutaneous coronary intervention (PCI) is challenging …
fibrillation(AF) undergoing percutaneous coronary intervention (PCI) is challenging …